72-kD (MMP-2) and 92-kD (MMP-9) type IV collagenase production and activity in different histologic types of lung cancer cells

被引:40
作者
Gonzalez-Avila, G
Iturria, C
Vadillo, F
Teran, L
Selman, M
Perez-Tamayo, R
机构
[1] Inst Nacl Enfermedades Resp, Dept Immunol, Mexico City, DF, Mexico
[2] Inst Nacl Nutr Salvador Zubiran, Dept Reprod Biol, Mexico City 14000, DF, Mexico
[3] Hosp Gen Mexico, Dept Expt Med, Mexico City, DF, Mexico
关键词
matrix metalloproteinases; lung cancer; gelatinase A; gelatinase B; TIMP-1; TIMP-2;
D O I
10.1159/000027989
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
In this study we examined the production of gelatinases A and B (MMP-2 and MMP-9), and their natural inhibitors TIMP-1 and TIMP-2 in cell lines derived from different histologic types of lung cancer. Gelatinolytic activity was measured by zymography and radiolabeled gelatin degradation. Immunocytochemistry and Western blot analysis were performed to corroborate the presence of immunoreactive MMP-2, MMP-9, TIMP-1 and TIMP-2 proteins. The highest gelatinolytic activity was identified in the cell extracts from a small-cell carcinoma cell line. MMP-9 was observed in all samples as a proenzyme, while MMP-2 was present as zymogen in the squamous-cell and in the small-cell carcinomas, and in its active form in one squamous-cell carcinoma cell line. TIMPs were also present in the neoplastic lung cell lines. TIMP-1 was observed in the media of all cells as a 21-kD band, and as TIMP-1 polymers with the exception of the small-cell carcinoma samples. TIMP-2 was found as higher-order molecular immunoreactive complexes that may correspond to proMMP-2/TIMP-2 complexes. These results demonstrate that lung neoplastic cells produce both MMP-2 and MMP-9 and their inhibitors, with the small-cell carcinoma cell extracts showing the highest enzymatic activity. This gelatinolytic activity fits well with the clinical metastatic behavior of this type of lung cancer.
引用
收藏
页码:5 / 16
页数:12
相关论文
共 44 条
[21]  
LU S, 1991, CANCER RES, V51, P6231
[22]   THE MATRIX-DEGRADING METALLOPROTEINASES [J].
MATRISIAN, LM .
BIOESSAYS, 1992, 14 (07) :455-463
[23]  
MOMIKI S, 1991, INVAS METAST, V11, P66
[24]  
MONTEAGUDO C, 1990, AM J PATHOL, V136, P585
[25]   REGULATION OF MATRIX METALLOPROTEINASE ACTIVITY [J].
MURPHY, G ;
WILLENBROCK, F ;
CRABBE, T ;
OSHEA, M ;
WARD, R ;
ATKINSON, S ;
OCONNELL, J ;
DOCHERTY, A .
INHIBITION OF MATRIX METALLOPROTEINASES: THERAPEUTIC POTENTIAL, 1994, 732 :31-41
[26]   INVITRO INVASIVE POTENTIAL AND TYPE-IV COLLAGENOLYTIC ACTIVITY OF HUMAN RENAL-CELL CARCINOMA-CELLS DERIVED FROM PRIMARY AND METASTATIC LESIONS [J].
OTANI, N ;
TSUKAMOTO, T ;
SAIKI, I ;
YONEDA, J ;
MITAKA, T ;
KUMAMOTO, Y .
JOURNAL OF UROLOGY, 1993, 149 (05) :1182-1185
[27]  
PONTON A, 1991, CANCER RES, V51, P2138
[28]  
POULSOM R, 1992, AM J PATHOL, V141, P389
[29]  
PYKE C, 1992, CANCER RES, V52, P1336
[30]   EXPRESSION AND LOCALIZATION OF MATRILYSIN, A MATRIX METALLOPROTEINASE, IN HUMAN ENDOMETRIUM DURING THE REPRODUCTIVE-CYCLE [J].
RODGERS, WH ;
OSTEEN, KG ;
MATRISIAN, LM ;
NAVRE, M ;
GIUDICE, LC ;
GORSTEIN, F .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1993, 168 (01) :253-260